Predicting Response to Chemotherapy in Advanced Breast Cancer
Author Information
Author(s): J Sjostrom, S Krajewski, K Franssila, E Niskanen, V-M Wasenius, S Nordling, JC Reed, C Blomqvist
Primary Institution: Helsinki University Central Hospital
Hypothesis
The study aimed to identify factors that could predict response to chemotherapy in breast cancer.
Conclusion
The study identified three factors—S-phase fraction, grade, and Bax—that independently predicted response to chemotherapy in advanced breast cancer.
Supporting Evidence
- S-phase fraction was the most powerful predictive factor for chemotherapy response.
- Low-grade tumors surprisingly responded better to chemotherapy.
- Bax expression was associated with better chemotherapy response.
Takeaway
Doctors can use certain tumor characteristics to figure out which breast cancer patients will respond well to chemotherapy, helping to avoid unnecessary treatment for others.
Methodology
A randomized trial with 173 patients receiving chemotherapy, followed by multivariate analysis of tumor biological factors.
Limitations
The study had exclusions due to unrepresentative histology and other malignancies, which may limit the generalizability of the findings.
Participant Demographics
Patients with measurable or evaluable metastatic breast cancer, with a history of previous cytotoxic treatment excluded.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website